Retrospective study of Kiyasu et al. performed on 1253 biopsies revealed that only 11% of DLBCL samples were PD-L1-positive (defined as ≥30% of neoplastic cells). The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.